I’m a Regulatory Affairs Specialist with 5 years in Class II device submissions and promotional review, considering sales but only if I can strictly uphold FDA requirements, the PhRMA/AdvaMed Codes, and Sunshine Act obligations. If you’ve transitioned, did a clinical specialist or associate sales role provide the best path to learn compliant, evidence-based discussions and push back on off-label pressure?
I moved from RA into a clinical specialist role, and the best training was weekly ride‑alongs where I owned fair balance and rehearsed a simple bridge — ‘I’ll follow up with an MLR‑approved resource’ — any time a question went off label. If you want more quota/negotiation reps, an associate spot is better, but clinical gave me the muscle memory to stick to the PI and the AdvaMed Code (https://www.advamed.org/wp-content/uploads/2020/01/Code-of-Ethics.pdf) in live calls.
Quick example: in my first associate role (Class II), I carried a one-page “claims crib” pulled from the 510(k) summary and cleared IFU, and we’d do a 60‑second pre‑call huddle to align on‑label phrasing and which Veeva‑approved leave‑behinds were allowed. I also logged any value transfers on the spot for Sunshine compliance, which built trust and kept promo review clean. If you want heavier clinical depth a clinical specialist seat works, but associate sales gave me faster reps with fair balance and the habit of saying, “If it’s not in the cleared IFU, we don’t say it.”.